The combination of Twist1‐siRNA and vorinostat given to pancreatic cancer cell lines has significantly reduced cell viability in CAPAN‐1 cells compared to other cells when used alone (Figure 2). This evidence concerns the gene TWIST1 and familial pancreatic carcinoma.